The importance of personal medicine: A qualitative study of resilience in people with psychiatric disabilities

Abstract

Background: Resilience does not refer to a magical state of invulnerability and the capacity for resilience does not end when one is diagnosed with a prolonged disorder or disease. Despite the enduring legacy of pessimism regarding resilience in the population of people diagnosed with psychiatric disorders, a majority do recover. Aim: The present study seeks to understand how people with psychiatric disorders demonstrate the capacity for resilience in the ways they use or do not use psychiatric medications in their daily lives. Method: A qualitative method and participatory action design was used to analyze interviews with 29 people diagnosed with psychiatric disorders. Results: When discussing their use of psychiatric medications, research participants also talked about non-pharmaceutical, personal medicine. Personal medicine was found to be those activities that gave life meaning and purpose, and that served to raise self-esteem, decrease symptoms, and avoid unwanted outcomes such as hospitalization. When psychiatric medications interfered with non-pharmaceutical personal medicine, non-adherence often occurred. Conclusion: People with psychiatric disorders demonstrate resilience through the use of non-pharmaceutical, personal medicine in the recovery process. This understanding suggests that medication adherence may be improved when clinicians inquire about patients' personal medicine and use pharmaceuticals to support, rather than interfere with, these self-assessed health resources.

Keywords

Medication adherence non-compliance person centered psychiatric disability qualitative research resilience recovery strengths

Get full access to this article

View all access options for this article.

References

Harding CM

Zahniser JH

Empirical correction of seven myths about schizophrenia with implications for treatment. Acta Psychiatr Scand1994;90:140—46.

Deegan PE

Recovery as a self-directed process of healing and transformation . Occup Ther Mental Health2001; 17:5—21.

Sullivan WP

A long and winding road: The process of recovery from severe mental illness. Innovations and Research in Clinical Services, Community Support & Rehabilitation1994;3:19—27.

Ridgway P.

ReStorying psychiatric disability: Learning from first person narrative accounts of recovery. Psychiatr Rehabil J2001;24:335—43.

Ridgway P.

Resilience and recovery from psychiatric disabilities: Links in concepts and research. A working paper. Lawrence, KS: University of Kansas, 2004.

Antonovsky A. Health, stress

and

coping

: New perspectives on mental and physical well-being. Washington, DC: Jossey-Bass , 1979.

Hollnagel H.

Malterud K.

Shifting attention from objective risk factors to patients' self-assessed health resources: A clinical model for general practice. Fam Pract1995; 12:423—9.

Malterud K.

Hollnagel H.

Women's self-assessed health resources . Scand J Prim Health Care1997;15:163—8.

US Department of Health and Human Services.

Mental health: Culture, race, and ethnicity — a supplement to mental health: a report of the surgeon general. Rockville, MD: US Department of Health and Human Services, Public Health Service, Office of the Surgeon General, 2001 [available at: http://www.surgeongeneral.gov/library ].

10.

Giorgi A.

The theory, practice, and evaluation of the phenomenological method as a qualitative research procedure. J Phenomenological

Psychology1997;28:235—60.

11.

Malterud K.

Qualitative research: standards, challenges, and guidelines. Lancet2001;358:483—8.

12.

Goldstrom I.

Campbell J.

Rogers J.

Lambert

Blacklow B.

Henderson M.

Manderscheid R.

National estimates for mental health mutual support groups, self-help organizations and consumer-operated services. Rockville, MD: Center for Mental Health Services, SAMHSA, 2004.

13.

Malterud K.

Hollnagel H.

Encouraging the strengths of women patients: A case study from general practice on empowering dialogues. Scand

J Public Health1999; 27:254—9.

14.

Strauss JS

Harding CM

Hafez H.

Liberman P.

The role of the patient in recovery from psychosis. In:

Strauss JS

Boker W

Brenner H

, editors. Psychosocial treatment of schizophrenia, Toronto: Hans Huber, 1987. p 160—6.

15.

Roe D.

Chopra M.

Rudnick A.

Persons with psychosis as active agents interacting with their disorder. Psychiatr Rehabil J2004 ;28:122—8.

16.

Strauss JS

Subjective experiences of schizophrenia: Toward a new dynamic psychiatry — II. Schizophr Bull1989;15:179—87.

17.

Rapp CA

The strengths model. New York: Oxford University Press, 1998.

18.

Rogers A.

Day JC

Williams B.

Randall F.

Wood P.

Healy D.

Bentall RP

The meaning and management of neuroleptic medication: A study of patients with a diagnosis of schizophrenia. Soc Sci Med1998;47:1313—23.

19.

Britten N.

Stevenson F.

Gafaranga J.

Barry C.

Bradley C.

The expression of aversion to medicines in general practice consultations. Soc Sci Med2004;59: 1495—1503.

20.

Scherman MH

Lowhagen O.

Drug compliance and identity: reasons for non-compliance — Experiences of medication from persons with asthma/allergy . Patient Education and Counseling2004;54:3—9.